AbbVie says it reconsidering deal with Shire

Published



CHICAGO (AP) — The drugmaker AbbVie said Tuesday it is having second thoughts about its deal to combine with British counterpart Shire after the U.S. government created new limitations on the tax benefits of incorporating overseas.

North Chicago, Illinois-based AbbVie Inc. said it notified Shire that its board intends to reconsider the recommendation it made in July that its shareholders back the proposed combination worth roughly $55 billion.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.